vs
Cardio Diagnostics Holdings, Inc.（CDIO）与ORAMED PHARMACEUTICALS INC.（ORMP）财务数据对比。点击上方公司名可切换其他公司
ORAMED PHARMACEUTICALS INC.自由现金流更多（$-468.0K vs $-5.9M）
Cardio Diagnostics Holdings, Inc.是一家专注于精准心血管医疗的企业，开发并商业化整合遗传与表观遗传技术的诊断检测产品，可早期识别冠心病、心力衰竭等心血管疾病，主要服务美国市场的医疗机构、临床实验室与患者。
Oramed制药公司成立于2006年，总部位于耶路撒冷，专注于开发口服给药系统，核心产品为用于治疗2型糖尿病的口服胰岛素胶囊，是一家公开上市企业，股票同时在纳斯达克资本市场和特拉维夫证券交易所挂牌交易。
CDIO vs ORMP — 直观对比
营收规模更大
CDIO
是对方的Infinity倍
$0
自由现金流更多
ORMP
多$5.4M
$-5.9M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6K | $0 |
| 净利润 | — | $10.0M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | — |
| 营收同比 | -21.2% | — |
| 净利润同比 | 3.6% | 198.2% |
| 每股收益（稀释后） | — | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDIOORMP
| Q4 25 | $3.6K | $0 | ||
| Q3 25 | $2.9K | $0 | ||
| Q2 25 | $7.5K | $0 | ||
| Q1 25 | — | $2.0M | ||
| Q4 24 | $4.5K | — | ||
| Q3 24 | $6.6K | — | ||
| Q2 24 | $7.9K | — | ||
| Q1 24 | $15.9K | — |
净利润CDIOORMP
| Q4 25 | — | $10.0M | ||
| Q3 25 | $-1.7M | $48.4M | ||
| Q2 25 | $-1.7M | $13.3M | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-4.2M | — |
毛利率CDIOORMP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CDIOORMP
| Q4 25 | — | — | ||
| Q3 25 | -59950.9% | — | ||
| Q2 25 | -22457.5% | — | ||
| Q1 25 | — | -225.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -21412.9% | — | ||
| Q2 24 | -16295.6% | — | ||
| Q1 24 | -26105.3% | — |
净利率CDIOORMP
| Q4 25 | — | — | ||
| Q3 25 | -60053.8% | — | ||
| Q2 25 | -22517.7% | — | ||
| Q1 25 | — | -382.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -21467.6% | — | ||
| Q2 24 | -16365.9% | — | ||
| Q1 24 | -26140.0% | — |
每股收益（稀释后）CDIOORMP
| Q4 25 | — | $0.25 | ||
| Q3 25 | $-0.98 | $1.13 | ||
| Q2 25 | $-0.97 | $0.31 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.73 | — | ||
| Q2 24 | $-1.71 | — | ||
| Q1 24 | $-5.93 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $51.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.0M | $199.7M |
| 总资产 | $7.8M | $230.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDIOORMP
| Q4 25 | — | $51.4M | ||
| Q3 25 | — | $57.1M | ||
| Q2 25 | — | $17.6M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CDIOORMP
| Q4 25 | $7.0M | $199.7M | ||
| Q3 25 | $8.2M | $203.3M | ||
| Q2 25 | $9.7M | $154.5M | ||
| Q1 25 | — | $140.8M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $3.7M | — | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $3.0M | — |
总资产CDIOORMP
| Q4 25 | $7.8M | $230.9M | ||
| Q3 25 | $8.8M | $220.5M | ||
| Q2 25 | $10.4M | $161.7M | ||
| Q1 25 | — | $147.5M | ||
| Q4 24 | $10.6M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $4.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-466.0K |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | $-468.0K |
| 自由现金流率自由现金流/营收 | -166361.5% | — |
| 资本支出强度资本支出/营收 | 5269.1% | — |
| 现金转化率经营现金流/净利润 | — | -0.05× |
| 过去12个月自由现金流最近4个季度 | $-14.3M | — |
8季度趋势，按日历期对齐
经营现金流CDIOORMP
| Q4 25 | $-5.7M | $-466.0K | ||
| Q3 25 | $-1.4M | $-1.6M | ||
| Q2 25 | $-1.6M | $-3.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-5.0M | — | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.2M | — | ||
| Q1 24 | $-1.2M | — |
自由现金流CDIOORMP
| Q4 25 | $-5.9M | $-468.0K | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-1.6M | $-3.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-1.3M | — |
自由现金流率CDIOORMP
| Q4 25 | -166361.5% | — | ||
| Q3 25 | -54509.7% | — | ||
| Q2 25 | -21273.1% | — | ||
| Q1 25 | — | -176.1% | ||
| Q4 24 | -115422.6% | — | ||
| Q3 24 | -17942.3% | — | ||
| Q2 24 | -17513.3% | — | ||
| Q1 24 | -7866.9% | — |
资本支出强度CDIOORMP
| Q4 25 | 5269.1% | — | ||
| Q3 25 | 5703.5% | — | ||
| Q2 25 | 250.1% | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 4759.9% | — | ||
| Q3 24 | 353.3% | — | ||
| Q2 24 | 2133.4% | — | ||
| Q1 24 | 125.5% | — |
现金转化率CDIOORMP
| Q4 25 | — | -0.05× | ||
| Q3 25 | — | -0.03× | ||
| Q2 25 | — | -0.27× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
